Royal College of Surgeons in Ireland
Curing the incurable- A case of refractory vasospastic angina.pdf (594.64 kB)

Curing the incurable: a case of refractory vasospastic angina

Download (594.64 kB)
journal contribution
posted on 2023-10-11, 07:52 authored by David Song, Mohamed Abdelghffar, Tasur Seen, Andrew Kim, XiongBin Lin, Saad Ahmad, Talal Almas, Julie Kanevsky

Vasospastic angina (VSA) is the spasm of coronary arteries causing transient myocardial ischemia. VSA is commonly managed with antispasmodic medications including calcium-channel blockers (CCB) and nitrates. When vasospasm is refractory to conventional medications, unconventional treatment modalities may be used for symptomatic relief (Tandon et al., 2019 Feb) [1]. There are several mediators of vasospasm, with serotonin playing a major role. Serotonin is a product of platelet aggregation and has multiple effects on the endothelium, which forms the basis of an unconventional treatment modality that may be used for symptomatic relief of VSA. In this case, a 44 year old female with a history of coronary artery disease (CAD) status post coronary artery bypass graft (CABG) with recent drug-eluting stent (DES) placement was admitted for shortness of breath and chest pain, found to have a positive stress echocardiogram (Echo), and had unremarkable coronary angiography. Given persistent symptoms while on optimal medical therapy and with negative coronary angiography, the diagnosis of refractory VSA was made. Patient was started on a serotonin receptor blocker with improvement of her symptoms. 



The original article is available at

Published Citation

Song D, et al. Curing the incurable: a case of refractory vasospastic angina. Ann Med Surg (Lond). 2021;71:102869.

Publication Date

15 September 2021

PubMed ID



  • Undergraduate Research


Elsevier B.V.


  • Published Version (Version of Record)